Geode Capital Management, LLC Summit Therapeutics Inc. Transaction History
Geode Capital Management, LLC
- $1.07 Trillion
- Q1 2024
A detailed history of Geode Capital Management, LLC transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 3,152,390 shares of SMMT stock, worth $24.6 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,152,390
Previous 3,085,666
2.16%
Holding current value
$24.6 Million
Previous $8.05 Million
62.05%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding SMMT
# of Institutions
107Shares Held
41.3MCall Options Held
103KPut Options Held
29.9K-
Black Rock Inc. New York, NY9.82MShares$76.6 Million0.0% of portfolio
-
State Street Corp Boston, MA8.11MShares$63.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.27MShares$56.7 Million0.0% of portfolio
-
Northern Trust Corp Chicago, IL1.07MShares$8.37 Million0.0% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA1.02MShares$7.93 Million0.0% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $1.57B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...